foxo4-dri cancer Development of a novel senolytic by precise disruption of FOXO4-p53 complex Buy FOXO4-DRI Peptide (Proxofim) -
Buy FOXO4 DRI Peptide (Proxofim) 10mg BiotechPeptides The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI 10mg vial Description RCpeptides FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness
Pay in 4 interest-free payments of $6.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



